The investment objective of this fund is to provide an above average income, together with prospects of capital appreciation over the longer term, derived mainly from a portfolio of securities in UK companies. The Halifax High Income Life and Pension funds invest directly into the Halifax UK Equity Income OEIC.
Name | % Net Assets |
---|---|
Royal Dutch Shell | 8.0% |
BP | 7.6% |
Vodafone Group | 7.4% |
GlaxoSmithKline | 6.5% |
Rio Tinto | 4.9% |
HSBC Hldgs | 4.6% |
AstraZeneca | 4.4% |
Compass Group | 2.8% |
Centrica | 2.5% |
Rolls-Royce Group | 2.3% |
Key | % Net Assets |
---|---|
Royal Dutch Shell | 8.0% |
BP | 7.6% |
Vodafone Group | 7.4% |
GlaxoSmithKline | 6.5% |
Other | 70.5% |
Date | 15-Nov-2024 |
---|---|
NAV | 102.10p |
Currency | GBP |
Change | 0.000p |
% | n/a |
YTD change | 6.34p |
YTD % | 6.62% |
Fund Inception | 09/01/1995 |
---|---|
Fund Manager | Tim Rees |
TER | - |
Minimum Investment | |
---|---|
Initial | £500 |
Additional | n/a |
Savings | £50 |
Charges | |
---|---|
Initial | n/a |
Annual Mang't | 1.50% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.02 |
Sharpe ratio | 0.03 |
You are here: research